CEMEX SAB-SPONS ADR PART CER (CX) Fundamental Analysis & Valuation

NYSE:CX • US1512908898

10.41 USD
+0.03 (+0.29%)
At close: Mar 13, 2026
10.41 USD
0 (0%)
After Hours: 3/13/2026, 8:19:08 PM

This CX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

4

Taking everything into account, CX scores 4 out of 10 in our fundamental rating. CX was compared to 13 industry peers in the Construction Materials industry. Both the profitability and financial health of CX have multiple concerns. CX scores decently on growth, while it is valued quite cheap. This could make an interesting combination.


Dividend Valuation Growth Profitability Health

3

1. CX Profitability Analysis

1.1 Basic Checks

  • CX had positive earnings in the past year.
  • In the past year CX had a positive cash flow from operations.
  • In the past 5 years CX has always been profitable.
  • CX had a positive operating cash flow in each of the past 5 years.
CX Yearly Net Income VS EBIT VS OCF VS FCFCX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B 2B

1.2 Ratios

  • The Return On Assets of CX (3.31%) is worse than 69.23% of its industry peers.
  • CX has a worse Return On Equity (7.21%) than 69.23% of its industry peers.
  • The Return On Invested Capital of CX (2.88%) is worse than 84.62% of its industry peers.
  • CX had an Average Return On Invested Capital over the past 3 years of 4.77%. This is below the industry average of 8.87%.
Industry RankSector Rank
ROA 3.31%
ROE 7.21%
ROIC 2.88%
ROA(3y)2.2%
ROA(5y)2.53%
ROE(3y)4.91%
ROE(5y)6.11%
ROIC(3y)4.77%
ROIC(5y)4.79%
CX Yearly ROA, ROE, ROICCX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 -5 -10 -15

1.3 Margins

  • Looking at the Profit Margin, with a value of 5.93%, CX is doing worse than 69.23% of the companies in the same industry.
  • In the last couple of years the Profit Margin of CX has declined.
  • CX has a worse Operating Margin (6.18%) than 84.62% of its industry peers.
  • In the last couple of years the Operating Margin of CX has declined.
  • The Gross Margin of CX (32.86%) is better than 69.23% of its industry peers.
  • In the last couple of years the Gross Margin of CX has remained more or less at the same level.
Industry RankSector Rank
OM 6.18%
PM (TTM) 5.93%
GM 32.86%
OM growth 3Y-14.66%
OM growth 5Y-9.41%
PM growth 3Y-6.41%
PM growth 5YN/A
GM growth 3Y2.07%
GM growth 5Y0.46%
CX Yearly Profit, Operating, Gross MarginsCX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20 30

2

2. CX Health Analysis

2.1 Basic Checks

  • CX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The debt/assets ratio for CX has been reduced compared to a year ago.
CX Yearly Shares OutstandingCX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B
CX Yearly Total Debt VS Total AssetsCX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

2.2 Solvency

  • Based on the Altman-Z score of 1.49, we must say that CX is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of CX (1.49) is worse than 61.54% of its industry peers.
  • The Debt to FCF ratio of CX is 10.19, which is on the high side as it means it would take CX, 10.19 years of fcf income to pay off all of its debts.
  • With a Debt to FCF ratio value of 10.19, CX perfoms like the industry average, outperforming 46.15% of the companies in the same industry.
  • A Debt/Equity ratio of 0.40 indicates that CX is not too dependend on debt financing.
  • The Debt to Equity ratio of CX (0.40) is better than 69.23% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF 10.19
Altman-Z 1.49
ROIC/WACC0.22
WACC13.34%
CX Yearly LT Debt VS Equity VS FCFCX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

2.3 Liquidity

  • CX has a Current Ratio of 0.83. This is a bad value and indicates that CX is not financially healthy enough and could expect problems in meeting its short term obligations.
  • CX has a worse Current ratio (0.83) than 84.62% of its industry peers.
  • CX has a Quick Ratio of 0.83. This is a bad value and indicates that CX is not financially healthy enough and could expect problems in meeting its short term obligations.
  • CX has a worse Quick ratio (0.62) than 76.92% of its industry peers.
Industry RankSector Rank
Current Ratio 0.83
Quick Ratio 0.62
CX Yearly Current Assets VS Current LiabilitesCX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

4

3. CX Growth Analysis

3.1 Past

  • The earnings per share for CX have decreased strongly by -93.26% in the last year.
  • Measured over the past years, CX shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -11.13% on average per year.
  • The Revenue for CX has decreased by -20.06% in the past year. This is quite bad
  • Measured over the past years, CX shows a small growth in Revenue. The Revenue has been growing by 4.71% on average per year.
EPS 1Y (TTM)-93.26%
EPS 3Y-11.13%
EPS 5YN/A
EPS Q2Q%-933.33%
Revenue 1Y (TTM)-20.06%
Revenue growth 3Y1.17%
Revenue growth 5Y4.71%
Sales Q2Q%9.66%

3.2 Future

  • CX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 181.48% yearly.
  • CX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.95% yearly.
EPS Next Y613.08%
EPS Next 2Y181.48%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year5.51%
Revenue Next 2Y4.85%
Revenue Next 3Y7.96%
Revenue Next 5Y5.95%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CX Yearly Revenue VS EstimatesCX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 5B 10B 15B 20B
CX Yearly EPS VS EstimatesCX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2 4 -4

7

4. CX Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 26.69, CX can be considered very expensive at the moment.
  • The rest of the industry has a similar Price/Earnings ratio as CX.
  • When comparing the Price/Earnings ratio of CX to the average of the S&P500 Index (25.70), we can say CX is valued inline with the index average.
  • A Price/Forward Earnings ratio of 3.74 indicates a rather cheap valuation of CX.
  • 100.00% of the companies in the same industry are more expensive than CX, based on the Price/Forward Earnings ratio.
  • CX's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 23.84.
Industry RankSector Rank
PE 26.69
Fwd PE 3.74
CX Price Earnings VS Forward Price EarningsCX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, CX is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
  • CX's Price/Free Cash Flow ratio is rather cheap when compared to the industry. CX is cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 22.69
EV/EBITDA 8.6
CX Per share dataCX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

  • CX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as CX's earnings are expected to grow with 181.48% in the coming years.
PEG (NY)0.04
PEG (5Y)N/A
EPS Next 2Y181.48%
EPS Next 3YN/A

6

5. CX Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 21.06%, CX is a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 2.11, CX pays a better dividend. On top of this CX pays more dividend than 100.00% of the companies listed in the same industry.
  • CX's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 21.06%

5.2 History

  • CX has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
CX Yearly Dividends per shareCX Yearly Dividends per shareYearly Dividends per share 2019 2024 2025 0.05 0.1 0.15 0.2

5.3 Sustainability

  • 13.28% of the earnings are spent on dividend by CX. This is a low number and sustainable payout ratio.
DP13.28%
EPS Next 2Y181.48%
EPS Next 3YN/A
CX Yearly Income VS Free CF VS DividendCX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B
CX Dividend Payout.CX Dividend Payout, showing the Payout Ratio.CX Dividend Payout.PayoutRetained Earnings

CX Fundamentals: All Metrics, Ratios and Statistics

CEMEX SAB-SPONS ADR PART CER

NYSE:CX (3/13/2026, 8:19:08 PM)

After market: 10.41 0 (0%)

10.41

+0.03 (+0.29%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryConstruction Materials
Earnings (Last)02-05
Earnings (Next)04-23
Inst Owners25.28%
Inst Owner Change-4.34%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap15.10B
Revenue(TTM)16.20B
Net Income(TTM)960.16M
Analysts78.67
Price Target12.86 (23.54%)
Short Float %0.62%
Short Ratio1.47
Dividend
Industry RankSector Rank
Dividend Yield 21.06%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP13.28%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-96.76%
Min EPS beat(2)-180.91%
Max EPS beat(2)-12.62%
EPS beat(4)0
Avg EPS beat(4)-61.97%
Min EPS beat(4)-180.91%
Max EPS beat(4)-2.91%
EPS beat(8)1
Avg EPS beat(8)140.94%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.42%
Min Revenue beat(2)-1.61%
Max Revenue beat(2)2.44%
Revenue beat(4)1
Avg Revenue beat(4)-1.78%
Min Revenue beat(4)-6.15%
Max Revenue beat(4)2.44%
Revenue beat(8)1
Avg Revenue beat(8)-3.6%
Revenue beat(12)2
Avg Revenue beat(12)-2.83%
Revenue beat(16)3
Avg Revenue beat(16)2.39%
PT rev (1m)0%
PT rev (3m)15.13%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0.58%
Revenue NQ rev (3m)0.58%
Revenue NY rev (1m)0.13%
Revenue NY rev (3m)0.13%
Valuation
Industry RankSector Rank
PE 26.69
Fwd PE 3.74
P/S 0.93
P/FCF 22.69
P/OCF 7.59
P/B 1.13
P/tB 3.64
EV/EBITDA 8.6
EPS(TTM)0.39
EY3.75%
EPS(NY)2.78
Fwd EY26.71%
FCF(TTM)0.46
FCFY4.41%
OCF(TTM)1.37
OCFY13.18%
SpS11.17
BVpS9.18
TBVpS2.86
PEG (NY)0.04
PEG (5Y)N/A
Graham Number8.97
Profitability
Industry RankSector Rank
ROA 3.31%
ROE 7.21%
ROCE 4.64%
ROIC 2.88%
ROICexc 3.17%
ROICexgc 5.95%
OM 6.18%
PM (TTM) 5.93%
GM 32.86%
FCFM 4.11%
ROA(3y)2.2%
ROA(5y)2.53%
ROE(3y)4.91%
ROE(5y)6.11%
ROIC(3y)4.77%
ROIC(5y)4.79%
ROICexc(3y)5.11%
ROICexc(5y)5.06%
ROICexgc(3y)9.64%
ROICexgc(5y)9.52%
ROCE(3y)7.68%
ROCE(5y)7.72%
ROICexgc growth 3Y-11.86%
ROICexgc growth 5Y-4.38%
ROICexc growth 3Y-12.5%
ROICexc growth 5Y-3.71%
OM growth 3Y-14.66%
OM growth 5Y-9.41%
PM growth 3Y-6.41%
PM growth 5YN/A
GM growth 3Y2.07%
GM growth 5Y0.46%
F-Score5
Asset Turnover0.56
Health
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF 10.19
Debt/EBITDA 2.32
Cap/Depr 102.66%
Cap/Sales 8.18%
Interest Coverage 2.25
Cash Conversion 86.85%
Profit Quality 69.32%
Current Ratio 0.83
Quick Ratio 0.62
Altman-Z 1.49
F-Score5
WACC13.34%
ROIC/WACC0.22
Cap/Depr(3y)100.55%
Cap/Depr(5y)96.93%
Cap/Sales(3y)7.66%
Cap/Sales(5y)7.33%
Profit Quality(3y)231.91%
Profit Quality(5y)171.51%
High Growth Momentum
Growth
EPS 1Y (TTM)-93.26%
EPS 3Y-11.13%
EPS 5YN/A
EPS Q2Q%-933.33%
EPS Next Y613.08%
EPS Next 2Y181.48%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-20.06%
Revenue growth 3Y1.17%
Revenue growth 5Y4.71%
Sales Q2Q%9.66%
Revenue Next Year5.51%
Revenue Next 2Y4.85%
Revenue Next 3Y7.96%
Revenue Next 5Y5.95%
EBIT growth 1Y-55.65%
EBIT growth 3Y-13.66%
EBIT growth 5Y-5.14%
EBIT Next Year100.06%
EBIT Next 3Y30.82%
EBIT Next 5YN/A
FCF growth 1Y11.3%
FCF growth 3Y18.2%
FCF growth 5Y-8.26%
OCF growth 1Y5.11%
OCF growth 3Y10.51%
OCF growth 5Y4.3%

CEMEX SAB-SPONS ADR PART CER / CX FAQ

What is the ChartMill fundamental rating of CEMEX SAB-SPONS ADR PART CER (CX) stock?

ChartMill assigns a fundamental rating of 4 / 10 to CX.


What is the valuation status for CX stock?

ChartMill assigns a valuation rating of 7 / 10 to CEMEX SAB-SPONS ADR PART CER (CX). This can be considered as Undervalued.


What is the profitability of CX stock?

CEMEX SAB-SPONS ADR PART CER (CX) has a profitability rating of 3 / 10.


Can you provide the financial health for CX stock?

The financial health rating of CEMEX SAB-SPONS ADR PART CER (CX) is 2 / 10.


How sustainable is the dividend of CEMEX SAB-SPONS ADR PART CER (CX) stock?

The dividend rating of CEMEX SAB-SPONS ADR PART CER (CX) is 6 / 10 and the dividend payout ratio is 13.28%.